Signaturefd LLC Has $871,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

Signaturefd LLC trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 8.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,900 shares of the company’s stock after selling 255 shares during the period. Signaturefd LLC’s holdings in HCA Healthcare were worth $871,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. GSA Capital Partners LLP bought a new position in HCA Healthcare in the 3rd quarter valued at about $567,000. Quest Partners LLC lifted its position in HCA Healthcare by 384.9% in the 3rd quarter. Quest Partners LLC now owns 3,171 shares of the company’s stock valued at $1,289,000 after acquiring an additional 2,517 shares in the last quarter. Pathstone Holdings LLC lifted its position in HCA Healthcare by 23.1% in the 3rd quarter. Pathstone Holdings LLC now owns 27,589 shares of the company’s stock valued at $11,213,000 after acquiring an additional 5,175 shares in the last quarter. Prospera Financial Services Inc lifted its position in HCA Healthcare by 204.2% in the 3rd quarter. Prospera Financial Services Inc now owns 2,917 shares of the company’s stock valued at $1,186,000 after acquiring an additional 1,958 shares in the last quarter. Finally, Banque Cantonale Vaudoise lifted its position in HCA Healthcare by 25.6% in the 3rd quarter. Banque Cantonale Vaudoise now owns 12,187 shares of the company’s stock valued at $4,953,000 after acquiring an additional 2,481 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 1.3 %

Shares of NYSE:HCA opened at $334.42 on Thursday. The firm has a fifty day moving average price of $320.53 and a two-hundred day moving average price of $343.97. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a market cap of $82.34 billion, a price-to-earnings ratio of 15.22, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the business posted $5.90 earnings per share. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s payout ratio is currently 13.11%.

Wall Street Analyst Weigh In

Several research firms have commented on HCA. Barclays decreased their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Royal Bank of Canada decreased their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. Morgan Stanley decreased their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.